{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:22:09Z","timestamp":1648758129215},"reference-count":27,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"1","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>Introducci\u00f3n. El 50 % de los episodios de sepsis neonatal se originan en la comunidad, con un gran porcentaje de mortalidad y complicaciones.Objetivo. Estimar los costos directos de la hospitalizaci\u00f3n por infecci\u00f3n neonatal adquirida en la comunidad en neonatos a t\u00e9rmino con bajo riesgo al nacer.Materiales y m\u00e9todos. Se utiliz\u00f3 la perspectiva del tercer pagador y la t\u00e9cnica de microcosteo; el horizonte de tiempo fue la duraci\u00f3n de la hospitalizaci\u00f3n. La determinaci\u00f3n de las situaciones generadoras de costos se obtuvo por medio de un consenso de expertos y se cuantificaron con base en la factura detallada de la atenci\u00f3n de 337 neonatos hospitalizados. Los costos de los medicamentos se calcularon con base en el Sistema de Informaci\u00f3n de Precios de Medicamentos (SISMED) y, el de los procedimientos, seg\u00fan los manuales tarifarios ISS 2001 con porcentaje de ajuste y el seguro obligatorio de accidentes de tr\u00e1fico (SOAT). Para incorporar la variabilidad de la informaci\u00f3n en la estimaci\u00f3n, se obtuvo una distribuci\u00f3n de los costos usando el m\u00e9todo de bootstrapping.Resultados. Se incluyeron las facturas por la atenci\u00f3n de 337 reci\u00e9n nacidos. El promedio de costos directos de la atenci\u00f3n por paciente fue de COL$ 2\u2019773.965 (desviaci\u00f3n est\u00e1ndar, DE=$ 198.813,5; IC95%: $ 2\u2019384.298 - $ 3\u2019163.632). Las principales categor\u00edas generadoras de costos fueron la internaci\u00f3n en la unidad de cuidados intensivos y las tecnolog\u00edas en salud. Los costos siguieron una una distribuci\u00f3n logar\u00edtmica normal (log-normal).Conclusiones. Las categor\u00edas con mayor impacto en los costos fueron la internaci\u00f3n en la unidad neonatal y las tecnolog\u00edas en salud. Los costos se ajustaron a una distribuci\u00f3n logar\u00edtmica normal.<\/jats:p>","DOI":"10.7705\/biomedica.5196","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T16:26:32Z","timestamp":1616516792000},"page":"87-98","update-policy":"http:\/\/dx.doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Costos directos de la infecci\u00f3n adquirida en la comunidad en neonatos a t\u00e9rmino con bajo riesgo al nacer, Cundinamarca, Colombia"],"prefix":"10.7705","volume":"41","author":[{"given":"Sergio Iv\u00e1n","family":"Agudelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Federico","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar Andr\u00e9s","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan David","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"102799","doi-asserted-by":"crossref","unstructured":"Yang X, Meng T. Admission of full-term infants to the neonatal intensive care unit: A 9.5-year review in a tertiary teaching hospital. J Matern Neonatal Med. 2020;33:3003-9. https:\/\/doi.org\/10.1080\/14767058.2019.1566901","DOI":"10.1080\/14767058.2019.1566901"},{"key":"102800","unstructured":"Santos Burgoa-Larra\u00f1aga L, Iglesias-Leboreiro J, Bernardez-Zapata I. Early discharge of the healthy newborn from the nursery of the Hospital Espa\u00f1ol de M\u00e9xico. Rev Med Inst Mex Seguro Soc. 2016;54:696-705."},{"key":"102801","doi-asserted-by":"crossref","unstructured":"Harron K, Gilbert R, Cromwell D, Oddie S, van der Meulen J. Newborn length of stay and risk of readmission. Paediatr Perinat Epidemiol. 2017;31:221-32. https:\/\/doi.org\/10.1111\/ppe.12359","DOI":"10.1111\/ppe.12359"},{"key":"102802","unstructured":"Waters D, Jawad I, Ahmad A, Luk\u0161i\u0107 I, Nair H, Zgaga L, et al. Aetiology of communityacquired neonatal sepsis in low- and middle-income countries. J Glob Health. 2011;1:154-70."},{"key":"102803","doi-asserted-by":"crossref","unstructured":"Weber MW, Carlin JB, Gatchalian S, Lehmann D, Muhe L, Mulholland EK. Predictors of neonatal sepsis in developing countries. Pediatr Infect Dis J. 2003;22:711-7. https:\/\/doi.org\/10.1097\/01.inf.0000078163.80807.88","DOI":"10.1097\/01.inf.0000078163.80807.88"},{"key":"102804","doi-asserted-by":"crossref","unstructured":"Osrin D, Vergnano S, Costello A. Serious bacterial infections in newborn infants in developing countries. Curr Opin Infect Dis. 2004;17:217-24. https:\/\/doi.org\/10.1097\/00001432-200406000-00008","DOI":"10.1097\/00001432-200406000-00008"},{"key":"102805","unstructured":"Downie L, Armiento R, Subhi R, Kelly J, Clifford V, Duke T. Community-acquired neonatal and infant sepsis in developing countries: Efficacy of WHO\u2019s currently recommended antibiotics -Systematic review and meta-analysis. Arch Dis Child. 2013;98:146-54. https:\/\/doi.org\/10.1136\/archdischild-2012-30203"},{"key":"102806","doi-asserted-by":"crossref","unstructured":"Jaramillo-Mej\u00eda MC, Chernichovsky D, Jim\u00e9nez-Mole\u00f3n JJ. Brechas regionales de la mortalidad infantil en Colombia. Rev Peru Med Exp Salud P\u00fablica. 2014;30:550-9.","DOI":"10.17843\/rpmesp.2013.304.232"},{"key":"102807","unstructured":"Stoll BJ, Gary L. Darmstadt AK. Neonatal infections: A global perspective. En: Wilson C, Nizet V, Maldonado Y, Remington J. Klein J, editors. Remington and Klein\u2019s Infectious diseases of the fetus and newborn infant. Eighth edition. Amsterdam: Saunders; 2016. p. 24-53."},{"key":"102808","doi-asserted-by":"crossref","unstructured":"Bulkowstein S, Ben-Shimol S, Givon-Lavi N, Melamed R, Shany E, Greenberg D. Comparison of early onset sepsis and community-acquired late onset sepsis in infants less than 3 months of age. BMC Pediatr. 2016;16:82. https:\/\/doi.org\/10.1186\/s12887-016-0618-6","DOI":"10.1186\/s12887-016-0618-6"},{"key":"102809","doi-asserted-by":"crossref","unstructured":"Lantos JD, Meadow WL. Costs and end-of-life care in the NICU: Lessons for the MICU? J Law, Med Ethics. 2011;39:194-200. https:\/\/doi.org\/10.1111\/j.1748-720X.2011.00588.x","DOI":"10.1111\/j.1748-720X.2011.00588.x"},{"key":"102810","doi-asserted-by":"crossref","unstructured":"Mugford M. Outcome and cost of neonatal intensive care. Curr Paediatr. 1994;4:30-2.","DOI":"10.1016\/0957-5839(94)90008-6"},{"key":"102811","unstructured":"WHO. Disease burden and mortality estimates. Geneva: WHO; 2019. Fecha de consulta: 6 de agosto de 2020. Disponible en: http:\/\/www.who.int\/healthinfo\/global_burden_disease\/estimates\/en\/"},{"key":"102812","doi-asserted-by":"crossref","unstructured":"Murthy S, John D, Godinho IP, Godinho MA, Guddattu V, Nair NS. A protocol for a systematic review of economic evaluation studies conducted on neonatal systemic infections in South Asia. Syst Rev. 2017;6:252. https:\/\/doi.org\/10.1186\/s13643-017-0648-7","DOI":"10.1186\/s13643-017-0648-7"},{"key":"102813","unstructured":"Mej\u00eda-Mej\u00eda A, Moreno-Viscaya M. Evaluaci\u00f3n econ\u00f3mica para la toma de decisiones en salud en Colombia. Superintendencia Nacional de Salud. 2014;5:70-7."},{"key":"102814","unstructured":"Departamento Administrativo Nacional de Estad\u00edsticas, DANE. Defunciones no fetales. Internet. Primeras causas de defunci\u00f3n. 2019. Fecha de consulta: 6 de agosto de 2020. Disponible en: https:\/\/www.dane.gov.co\/index.php\/estadisticas-por-tema\/salud\/nacimientosy-defunciones\/defunciones-no-fetales"},{"key":"102815","doi-asserted-by":"crossref","unstructured":"Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000\u201315: An updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388:3027-35. https:\/\/doi.org\/10.1016\/S0140-6736(16)31593-8","DOI":"10.1016\/S0140-6736(16)31593-8"},{"key":"102816","doi-asserted-by":"crossref","unstructured":"Cheah IGS. Economic assessment of neonatal intensive care. Transl Pediatr. 2019;8:246-56. https:\/\/doi.org\/10.21037\/tp.2019.07.03","DOI":"10.21037\/tp.2019.07.03"},{"key":"102817","doi-asserted-by":"crossref","unstructured":"Alvarado-Jaramillo JC, Gonz\u00e1les-Ramos AJ, Mendoza-Arana P. An\u00e1lisis de costos en dos unidades de cuidados intensivos pedi\u00e1tricos del Ministerio de Salud del Per\u00fa. Anales de la Facultad de Medicina. 2011;72:249-54.","DOI":"10.15381\/anales.v72i4.1078"},{"key":"102818","doi-asserted-by":"crossref","unstructured":"Shanmugasundaram R, Padmapriya E, Shyamala J. Cost of neonatal intensive care. Indian J Pediatr. 1998;65:249-55. https:\/\/doi.org\/10.1007\/BF02752301","DOI":"10.1007\/BF02752301"},{"key":"102819","doi-asserted-by":"crossref","unstructured":"Profit J, Lee D, Zupancic JA, Papile L, Guti\u00e9rrez C, Goldie SJ, et al. Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in M\u00e9xico. PLoS Med. 2010;7:e1000379. https:\/\/doi.org\/10.1371\/journal.pmed.1000379","DOI":"10.1371\/journal.pmed.1000379"},{"key":"102820","unstructured":"Amador-Mor\u00e1n R, Labrada-Despaigne A, Campo-Gonz\u00e1lez A, D\u00edaz-Aguilar R. Costo-beneficio en una unidad de cuidados intensivos neonatales. Rev Cubana Pediatr. 2011;83:166-72."},{"key":"102821","doi-asserted-by":"crossref","unstructured":"Lassi ZS, Bhutta ZA. Community-based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes. Cochrane Database Syst Rev. 2015;3:CD007754. https:\/\/doi.org\/10.1002\/14651858.CD007754.pub3","DOI":"10.1002\/14651858.CD007754.pub3"},{"key":"102822","doi-asserted-by":"crossref","unstructured":"Nkonki LL, Chola LL, Tugendhaft AA, Hofman KK. Modelling the cost of community interventions to reduce child mortality in South Africa using the Lives Saved Tool (LiST). BMJ Open. 2017;7:e011425. https:\/\/doi.org\/10.1136\/bmjopen-2016-011425","DOI":"10.1136\/bmjopen-2016-011425"},{"key":"102823","doi-asserted-by":"crossref","unstructured":"Mangham-Jefferies L, Pitt C, Cousens S, Mills A, Schellenberg J. Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: A systematic review. BMC Pregnancy Childbirth. 2014;14:243. https:\/\/doi.org\/10.1186\/1471-2393-14-243","DOI":"10.1186\/1471-2393-14-243"},{"key":"102824","doi-asserted-by":"crossref","unstructured":"Bhutta ZA, Das JK, Bahl R, Lawn JE, Salam RA, Paul VK, et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet. 2014;384:347-70. https:\/\/doi.org\/10.1016\/S0140-6736(14)60792-3","DOI":"10.1016\/S0140-6736(14)60792-3"},{"key":"102825","doi-asserted-by":"crossref","unstructured":"Ranjeva SL, Warf BC, Schiff SJ. Economic burden of neonatal sepsis in sub-Saharan Africa. BMJ Glob Health. 2018;3:e000347. https:\/\/doi.org\/10.1136\/bmjgh-2017-000347","DOI":"10.1136\/bmjgh-2017-000347"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5196\/4662","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5196\/4662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T21:46:15Z","timestamp":1618436775000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/5196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3,19]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.5196","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"2021-03-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Original article","name":"content_type","label":"Content Type"}]}}